NCT02472652 - Aripiprazole, Abilify Maintena Collaborative Clinical Protocol | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 1, 2017

Conditions

Sexual Dysfunction

Interventions

DRUG

Abilify Maintena

For subjects who meet inclusion/exclusion criteria for this study a switch from Palliperidone Palmitate or Risperidone injectable will be made to Abilify Maintena for a 3 month period to determine if there are changes in sexual dysfunction ratings over this time period

Trial Locations (1)

86442

Mohammed Ramadan MD Private Practice, Bullhead City